{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T04:21:59Z","timestamp":1684556519462},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T00:00:00Z","timestamp":1381449600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1038\/pr.2013.169","type":"journal-article","created":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T15:53:42Z","timestamp":1381506822000},"page":"38-44","source":"Crossref","is-referenced-by-count":4,"title":["Synergistic protective effects of mizoribine and angiotensin II receptor blockade on cyclosporine A nephropathy in rats"],"prefix":"10.1038","volume":"75","author":[{"given":"Amane","family":"Endo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonosuke","family":"Someya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayu","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yayoi","family":"Murano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Sakuraya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichiro","family":"Fujinaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Ohtomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitohiko","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,11]]},"reference":[{"key":"BFpr2013169_CR1","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1136\/adc.2005.080960","volume":"91","author":"S Fujinaga","year":"2006","unstructured":"Fujinaga S, Kaneko K, Muto T, Ohtomo Y, Murakami H, Yamashiro Y . Independent risk factors for chronic cyclosporine induced nephropathy in children with nephrotic syndrome. Arch Dis Child 2006;91:666\u201370.","journal-title":"Arch Dis Child"},{"key":"BFpr2013169_CR2","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/j.1523-1755.1998.00835.x","volume":"53","author":"SE Thomas","year":"1998","unstructured":"Thomas SE, Andoh TF, Pichler RH, et al. Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis. Kidney Int 1998;53:897\u2013908.","journal-title":"Kidney Int"},{"key":"BFpr2013169_CR3","doi-asserted-by":"publisher","first-page":"775","DOI":"10.7164\/antibiotics.27.775","volume":"27","author":"K Mizuno","year":"1974","unstructured":"Mizuno K, Tsujino M, Takada M, Hayashi M, Atsumi K . Studies on bredinin. I. Isolation, characterization and biological properties. J Antibiot 1974;27:775\u201382.","journal-title":"J Antibiot"},{"key":"BFpr2013169_CR4","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1016\/S0022-5347(01)68242-9","volume":"158","author":"T Sakai","year":"1997","unstructured":"Sakai T, Kawamura T, Shirasawa T . Mizoribine improves renal tubulointerstitial fibrosis in unilateral ureteral obstruction (UUO)-treated rat by inhibiting the infiltration of macrophages and the expression of alpha-smooth muscle actin. J Urol 1997;158:2316\u201322.","journal-title":"J Urol"},{"key":"BFpr2013169_CR5","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1248\/bpb.35.705","volume":"35","author":"H Yamabe","year":"2012","unstructured":"Yamabe H, Shimada M, Murakami R, Fujita T, Shimaya Y, Nakamura N . Mizoribine suppresses proliferation of rat glomerular epithelial cells in culture and inhibits increase of monocyte chemoattractant protein-1 and macrophage inflammatory protein-2 stimulated by thrombin. Biol Pharm Bull 2012;35:705\u20138.","journal-title":"Biol Pharm Bull"},{"key":"BFpr2013169_CR6","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1203\/PDR.0b013e3181b9b48a","volume":"66","author":"S Hara","year":"2009","unstructured":"Hara S, Umino D, Someya T, et al. Protective effects of mizoribine on cyclosporine A nephropathy in rats. Pediatr Res 2009;66:524\u20137.","journal-title":"Pediatr Res"},{"key":"BFpr2013169_CR7","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1046\/j.1523-1755.2001.060003847.x","volume":"60","author":"CW Yang","year":"2001","unstructured":"Yang CW, Ahn HJ, Kim WY, et al. Influence of the renin-angiotensin system on epidermal growth factor expression in normal and cyclosporine-treated rat kidney. Kidney Int 2001;60:847\u201357.","journal-title":"Kidney Int"},{"key":"BFpr2013169_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2174\/1389200023337964","volume":"3","author":"M Lassila","year":"2002","unstructured":"Lassila M . Interaction of cyclosporine A and the renin-angiotensin system; new perspectives. Curr Drug Metab 2002;3:61\u201371.","journal-title":"Curr Drug Metab"},{"key":"BFpr2013169_CR9","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/00007890-200203150-00022","volume":"73","author":"J Lin","year":"2002","unstructured":"Lin J, Valeri AM, Markowitz GS, D\u2019Agati VD, Cohen DJ, Radhakrishnan J . Angiotensin converting enzyme inhibition in chronic allograft nephropathy. Transplantation 2002;73:783\u20138.","journal-title":"Transplantation"},{"key":"BFpr2013169_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/01.TP.0000045034.48833.51","volume":"75","author":"CW Yang","year":"2003","unstructured":"Yang CW, Ahn HJ, Kim WY, et al. Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy. Transplantation 2003;75:309\u201315.","journal-title":"Transplantation"},{"key":"BFpr2013169_CR11","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/BF00165637","volume":"338","author":"E M\u00fcller-Schweinitzer","year":"1988","unstructured":"M\u00fcller-Schweinitzer E . Changes in the venous compliance by bradykinin and angiotensin II and its significance for the vascular effects of cyclosporine-A. Naunyn Schmiedebergs Arch Pharmacol 1988;338:699\u2013703.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"BFpr2013169_CR12","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1097\/00007890-199310000-00022","volume":"56","author":"J Julien","year":"1993","unstructured":"Julien J, Farge D, Kreft-Jais C, et al. Cyclosporine-induced stimulation of the renin-angiotensin system after liver and heart transplantation. Transplantation 1993;56:885\u201391.","journal-title":"Transplantation"},{"key":"BFpr2013169_CR13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0014-2999(93)90066-Q","volume":"233","author":"Y Takeda","year":"1993","unstructured":"Takeda Y, Itoh Y, Yoneda T, Miyamori I, Takeda R . Cyclosporine A induces endothelin-1 release from cultured rat vascular smooth muscle cells. Eur J Pharmacol 1993;233:299\u2013301.","journal-title":"Eur J Pharmacol"},{"key":"BFpr2013169_CR14","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJM198409133111103","volume":"311","author":"BD Myers","year":"1984","unstructured":"Myers BD, Ross J, Newton L, Luetscher J, Perlroth M . Cyclosporine-associated chronic nephropathy. N Engl J Med 1984;311:699\u2013705.","journal-title":"N Engl J Med"},{"key":"BFpr2013169_CR15","first-page":"356","volume":"49","author":"MJ Mihatsch","year":"1998","unstructured":"Mihatsch MJ, Kyo M, Morozumi K, Yamaguchi Y, Nickeleit V, Ryffel B . The side-effects of ciclosporine-A and tacrolimus. Clin Nephrol 1998;49:356\u201363.","journal-title":"Clin Nephrol"},{"issue":"2 Suppl","key":"BFpr2013169_CR16","doi-asserted-by":"publisher","first-page":"251S","DOI":"10.1016\/j.transproceed.2004.01.027","volume":"36","author":"K Morozumi","year":"2004","unstructured":"Morozumi K, Takeda A, Uchida K, Mihatsch MJ . Cyclosporine nephrotoxicity: how does it affect renal allograft function and transplant morphology? Transplant Proc 2004;36(2 Suppl):251S\u20136S.","journal-title":"Transplant Proc"},{"issue":"4 Pt 2","key":"BFpr2013169_CR17","first-page":"F595","volume":"275","author":"Z Zhong","year":"1998","unstructured":"Zhong Z, Arteel GE, Connor HD, et al. Cyclosporin A increases hypoxia and free radical production in rat kidneys: prevention by dietary glycine. Am J Physiol 1998;275(4 Pt 2):F595\u2013604.","journal-title":"Am J Physiol"},{"key":"BFpr2013169_CR18","doi-asserted-by":"publisher","first-page":"F445","DOI":"10.1152\/ajprenal.00037.2007","volume":"293","author":"A Djamali","year":"2007","unstructured":"Djamali A . Oxidative stress as a common pathway to chronic tubulointerstitial injury in kidney allografts. Am J Physiol Renal Physiol 2007;293:F445\u201355.","journal-title":"Am J Physiol Renal Physiol"},{"key":"BFpr2013169_CR19","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1681\/ASN.V641186","volume":"6","author":"RH Pichler","year":"1995","unstructured":"Pichler RH, Franceschini N, Young BA, et al. Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin. J Am Soc Nephrol 1995;6:1186\u201396.","journal-title":"J Am Soc Nephrol"},{"key":"BFpr2013169_CR20","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/ki.1996.165","volume":"49","author":"FS Shihab","year":"1996","unstructured":"Shihab FS, Andoh TF, Tanner AM, et al. Role of transforming growth factor-beta 1 in experimental chronic cyclosporine nephropathy. Kidney Int 1996;49:1141\u201351.","journal-title":"Kidney Int"},{"key":"BFpr2013169_CR21","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1046\/j.1523-1755.2001.059002498.x","volume":"59","author":"M Islam","year":"2001","unstructured":"Islam M, Burke JF Jr, McGowan TA, et al. Effect of anti-transforming growth factor-beta antibodies in cyclosporine-induced renal dysfunction. Kidney Int 2001;59:498\u2013506.","journal-title":"Kidney Int"},{"key":"BFpr2013169_CR22","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/ki.1995.312","volume":"48","author":"BA Young","year":"1995","unstructured":"Young BA, Burdmann EA, Johnson RJ, et al. Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity. Kidney Int 1995;48:439\u201348.","journal-title":"Kidney Int"},{"key":"BFpr2013169_CR23","doi-asserted-by":"publisher","first-page":"887","DOI":"10.2174\/0929867043455648","volume":"11","author":"KW Pankiewicz","year":"2004","unstructured":"Pankiewicz KW, Patterson SE, Black PL, et al. Cofactor mimics as selective inhibitors of NAD-dependent inosine monophosphate dehydrogenase (IMPDH)\u2013the major therapeutic target. Curr Med Chem 2004;11:887\u2013900.","journal-title":"Curr Med Chem"},{"key":"BFpr2013169_CR24","doi-asserted-by":"publisher","first-page":"c73","DOI":"10.1159\/000151721","volume":"110","author":"H Tanaka","year":"2008","unstructured":"Tanaka H, Oki E, Tsuruga K, et al. Mizoribine treatment of young patients with severe lupus nephritis: a clinicopathologic study by the tohoku pediatric study group. Nephron Clin Pract 2008;110:c73\u20139.","journal-title":"Nephron Clin Pract"},{"key":"BFpr2013169_CR25","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1159\/000082202","volume":"24","author":"Y Kawasaki","year":"2004","unstructured":"Kawasaki Y, Hosoya M, Suzuki J, et al. Efficacy of multidrug therapy combined with mizoribine in children with diffuse IgA nephropathy in comparison with multidrug therapy without mizoribine and with methylprednisolone pulse therapy. Am J Nephrol 2004;24:576\u201381.","journal-title":"Am J Nephrol"},{"key":"BFpr2013169_CR26","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1046\/j.1523-1755.2000.00168.x","volume":"58","author":"K Yoshioka","year":"2000","unstructured":"Yoshioka K, Ohashi Y, Sakai T, et al. A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome. Kidney Int 2000;58:317\u201324.","journal-title":"Kidney Int"},{"key":"BFpr2013169_CR27","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1159\/000046065","volume":"89","author":"N Sato","year":"2001","unstructured":"Sato N, Shiraiwa K, Kai K, et al. Mizoribine ameliorates the tubulointerstitial fibrosis of obstructive nephropathy. Nephron 2001;89:177\u201385.","journal-title":"Nephron"},{"key":"BFpr2013169_CR28","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3109\/s10165-010-0312-8","volume":"20","author":"K Matsui","year":"2010","unstructured":"Matsui K, Ueda H, Terada M, Azuma N, Okamura H, Sano H . Mizoribine protects against bleomycin-induced lung injury. Mod Rheumatol 2010;20:471\u20137.","journal-title":"Mod Rheumatol"},{"key":"BFpr2013169_CR29","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/ki.1997.380","volume":"52","author":"FS Shihab","year":"1997","unstructured":"Shihab FS, Bennett WM, Tanner AM, Andoh TF . Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathy. Kidney Int 1997;52:660\u201373.","journal-title":"Kidney Int"},{"key":"BFpr2013169_CR30","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1093\/ndt\/gfq537","volume":"26","author":"HE Yoon","year":"2011","unstructured":"Yoon HE, Ghee JY, Piao S, et al. Angiotensin II blockade upregulates the expression of Klotho, the anti-ageing gene, in an experimental model of chronic cyclosporine nephropathy. Nephrol Dial Transplant 2011;26:800\u201313.","journal-title":"Nephrol Dial Transplant"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/pr2013169.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr2013169","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr2013169.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:58:27Z","timestamp":1684472307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/pr2013169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,11]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["BFpr2013169"],"URL":"https:\/\/doi.org\/10.1038\/pr.2013.169","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,11]]}}}